Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022
Noah Kojima,Katherine Adams,Wesley H Self,Manjusha Gaglani,Tresa McNeal,Shekhar Ghamande,Jay S Steingrub,Nathan I Shapiro,Abhijit Duggal,Laurence W Busse,Matthew E Prekker,Ithan D Peltan,Samuel M Brown,David N Hager,Harith Ali,Michelle N Gong,Amira Mohamed,Matthew C Exline,Akram Khan,Jennifer G Wilson,Nida Qadir,Steven Y Chang,Adit A Ginde,Cori A Withers,Nicholas M Mohr,Christopher Mallow,Emily T Martin,Adam S Lauring,Nicholas J Johnson,Jonathan D Casey,William B Stubblefield,Kevin W Gibbs,Jennie H Kwon,Adrienne Baughman,James D Chappell,Kimberly W Hart,Ian D Jones,Jillian P Rhoads,Sydney A Swan,Kelsey N Womack,Yuwei Zhu,Diya Surie,Meredith L McMorrow,Manish M Patel,Mark W Tenforde,Investigating Respiratory Viruses in the Acutely Ill (IVY) Network,Nicole Calhoun,Kempapura Murthy,Judy Herrick,Amanda McKillop,Eric Hoffman,Martha Zayed,Michael Smith,Jay Steingrub,Lori-Ann Kozikowski,Lesley De Souza,Scott Ouellette,Michael Bolstad,Brianna Coviello,Robert Ciottone,Arnaldo Devilla,Ana Grafals,Conor Higgins,Carlo Ottanelli,Kimberly Redman,Douglas Scaffidi,Alexander Weingart,Meredith McMorrow,Jennifer DeCuir,Natalie Thornburg,Brendan Flannery,Nathaniel Lewis,Mark Tenforde,Manish Patel,Omar Mehkri,Megan Mitchell,Zachary Griffith,Connery Brennan,Kiran Ashok,Bryan Poynter,Laurence Busse,Caitlin Ten Lohuis,Nicholas Stanley,Sophia Zhang,Matthew Prekker,Heidi Erickson,Anne Frosch,Audrey Hendrickson,Sean Caspers,Walker Tordsen,Olivia Kaus,Tyler Scharber,Ithan Peltan,Samuel Brown,Jenna Lumpkin,Cassie Smith,Hunter Marshall,Richard E Rothman,Michelle Gong,Rahul Nair,Jen-Ting Tina Chen,Matthew Exline,Sarah Karow,Emily Robart,Paulo Nunes Maldonado,Maryiam Khan,Preston So,Madison So,Elizabeth Schwartz,Mena Botros,Catherine L Hough,Haeun Jung,Jesus Martinez,Andrea Luong,Bao Huynh,Habiba Ibrahim,Cynthia Villanueva-Vargas,Juliana Villanueva-Vargas,Suha Quadri,Alexandra June Gordon,Cynthia Perez,Lily Lau,Ismail Hakki Bekiroglu,Steven Chang,Trevor Frankel,Omai Garner,Sukantha Chandrasekaran,Adit Ginde,David Douin,Kelly Jensen,David Huynh,Aimee Steinwand,Cori Withers,Nicholas Mohr,Anne Zepeski,Paul Nassar,Shannon Landers,Karin Nielsen,Noble Briggs,Cathy Fairfield,Chris Mallow,Carolina Rivas,Emily Martin,Arnold Monto,Adam Lauring,E J McSpadden,Rachel Truscon,Anne Kaniclides,Lara Thomas,Ramsay Bielak,Weronika Damek Valvano,Rebecca Fong,William J Fitzsimmons,Christopher Blair,Julie Gilbert,Leigh Baker,Nicholas Johnson,Vasisht Srinivasan,Christine D Crider,Kyle A Steinbock,Thomas C Paulsen,Layla A Anderson,H Keipp Talbot,Carlos Grijalva,Ian Jones,Natasha Halasa,James Chappell,Kelsey Womack,Jillian Rhoads,Christy Kampe,Jakea Johnson,Kim Hart,Todd Rice,Jonathan Casey,Laura L Short,Lauren J Ezzell,Margaret E Whitsett,Rendie E McHenry,Samarian J Hargrave,Marcia Blair,Jennifer L Luther,Claudia Guevara Pulido,Bryan P M Peterson,D Clark Files,Kevin Gibbs,Mary LaRose,Leigha Landreth,Madeline Hicks,Lisa Parks,Hilary Babcock,Jennie Kwon,Jahnavi Bongu,David McDonald,Candice Cass,Sondra Seiler,David Park,Tiffany Hink,Meghan Wallace,Carey-Ann Burnham,Olivia G Arter
DOI: https://doi.org/10.1093/cid/ciad276
2023-08-22
Abstract:Introduction: Understanding the changing epidemiology of adults hospitalized with coronavirus disease 2019 (COVID-19) informs research priorities and public health policies. Methods: Among adults (≥18 years) hospitalized with laboratory-confirmed, acute COVID-19 between 11 March 2021, and 31 August 2022 at 21 hospitals in 18 states, those hospitalized during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron-predominant period (BA.1, BA.2, BA.4/BA.5) were compared to those from earlier Alpha- and Delta-predominant periods. Demographic characteristics, biomarkers within 24 hours of admission, and outcomes, including oxygen support and death, were assessed. Results: Among 9825 patients, median (interquartile range [IQR]) age was 60 years (47-72), 47% were women, and 21% non-Hispanic Black. From the Alpha-predominant period (Mar-Jul 2021; N = 1312) to the Omicron BA.4/BA.5 sublineage-predominant period (Jun-Aug 2022; N = 1307): the percentage of patients who had ≥4 categories of underlying medical conditions increased from 11% to 21%; those vaccinated with at least a primary COVID-19 vaccine series increased from 7% to 67%; those ≥75 years old increased from 11% to 33%; those who did not receive any supplemental oxygen increased from 18% to 42%. Median (IQR) highest C-reactive protein and D-dimer concentration decreased from 42.0 mg/L (9.9-122.0) to 11.5 mg/L (2.7-42.8) and 3.1 mcg/mL (0.8-640.0) to 1.0 mcg/mL (0.5-2.2), respectively. In-hospital death peaked at 12% in the Delta-predominant period and declined to 4% during the BA.4/BA.5-predominant period. Conclusions: Compared to adults hospitalized during early COVID-19 variant periods, those hospitalized during Omicron-variant COVID-19 were older, had multiple co-morbidities, were more likely to be vaccinated, and less likely to experience severe respiratory disease, systemic inflammation, coagulopathy, and death.